These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [The clinical characteristics and prognosis of acute myocardial infarction complicated by cardiogenic shock]. Xu L; Ge YG; Liu JM; Wang HS; Yu LP; Ni ZH; Cui L Zhonghua Nei Ke Za Zhi; 2008 Jun; 47(6):472-4. PubMed ID: 19040063 [TBL] [Abstract][Full Text] [Related]
28. Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. Thiele H; Schuler G; Neumann FJ; Hausleiter J; Olbrich HG; Schwarz B; Hennersdorf M; Empen K; Fuernau G; Desch S; de Waha S; Eitel I; Hambrecht R; Böhm M; Kurowski V; Lauer B; Minden HH; Figulla HR; Braun-Dullaeus RC; Strasser RH; Rochor K; Maier SK; Möllmann H; Schneider S; Ebelt H; Werdan K; Zeymer U Am Heart J; 2012 Jun; 163(6):938-45. PubMed ID: 22709745 [TBL] [Abstract][Full Text] [Related]
29. Correlates for mortality in patients presented with acute myocardial infarct complicated by cardiogenic shock. Minha S; Barbash IM; Dvir D; Ben-Dor I; Loh JP; Pendyala LK; Satler LF; Pichard AD; Torguson R; Waksman R Cardiovasc Revasc Med; 2014 Jan; 15(1):13-7. PubMed ID: 24444472 [TBL] [Abstract][Full Text] [Related]
30. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Thiele H; Zeymer U; Neumann FJ; Ferenc M; Olbrich HG; Hausleiter J; de Waha A; Richardt G; Hennersdorf M; Empen K; Fuernau G; Desch S; Eitel I; Hambrecht R; Lauer B; Böhm M; Ebelt H; Schneider S; Werdan K; Schuler G; Lancet; 2013 Nov; 382(9905):1638-45. PubMed ID: 24011548 [TBL] [Abstract][Full Text] [Related]
31. Moving Beyond SHOCK: New Paradigms in the Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock. Kalavrouziotis D; Rodés-Cabau J; Mohammadi S Can J Cardiol; 2017 Jan; 33(1):36-43. PubMed ID: 28024554 [TBL] [Abstract][Full Text] [Related]
32. Sex-Specific Management in Patients With Acute Myocardial Infarction and Cardiogenic Shock: A Substudy of the CULPRIT-SHOCK Trial. Rubini Gimenez M; Zeymer U; Desch S; de Waha-Thiele S; Ouarrak T; Poess J; Meyer-Saraei R; Schneider S; Fuernau G; Stepinska J; Huber K; Windecker S; Montalescot G; Savonitto S; Jeger RV; Thiele H Circ Cardiovasc Interv; 2020 Mar; 13(3):e008537. PubMed ID: 32151161 [TBL] [Abstract][Full Text] [Related]
33. Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States. Shah M; Patnaik S; Patel B; Ram P; Garg L; Agarwal M; Agrawal S; Arora S; Patel N; Wald J; Jorde UP Clin Res Cardiol; 2018 Apr; 107(4):287-303. PubMed ID: 29134345 [TBL] [Abstract][Full Text] [Related]
34. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Barron HV; Every NR; Parsons LS; Angeja B; Goldberg RJ; Gore JM; Chou TM; Am Heart J; 2001 Jun; 141(6):933-9. PubMed ID: 11376306 [TBL] [Abstract][Full Text] [Related]
35. Impact of the Change in ESC Guidelines on Clinical Characteristics and Outcomes of Cardiogenic Shock Patients Receiving IABP Therapy. Nevzorov R; Daum A; Jafari J; Yosefy C; Gallego-Colon E Cardiovasc Revasc Med; 2020 Jan; 21(1):46-51. PubMed ID: 31759912 [TBL] [Abstract][Full Text] [Related]
36. Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? Hochman JS; Buller CE; Sleeper LA; Boland J; Dzavik V; Sanborn TA; Godfrey E; White HD; Lim J; LeJemtel T J Am Coll Cardiol; 2000 Sep; 36(3 Suppl A):1063-70. PubMed ID: 10985706 [TBL] [Abstract][Full Text] [Related]
37. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. Babaev A; Frederick PD; Pasta DJ; Every N; Sichrovsky T; Hochman JS; JAMA; 2005 Jul; 294(4):448-54. PubMed ID: 16046651 [TBL] [Abstract][Full Text] [Related]
38. Predictors of survival and ability to wean from short-term mechanical circulatory support device following acute myocardial infarction complicated by cardiogenic shock. Garan AR; Eckhardt C; Takeda K; Topkara VK; Clerkin K; Fried J; Masoumi A; Demmer RT; Trinh P; Yuzefpolskaya M; Naka Y; Burkhoff D; Kirtane A; Colombo PC; Takayama H Eur Heart J Acute Cardiovasc Care; 2018 Dec; 7(8):755-765. PubMed ID: 29094607 [TBL] [Abstract][Full Text] [Related]
39. The role of different mechanical circulatory support devices and their timing of implantation on myocardial damage and mid-term recovery in acute myocardial infarction related cardiogenic shock. Pieri M; Sorrentino T; Oppizzi M; Melisurgo G; Lembo R; Colombo A; Zangrillo A; Pappalardo F J Interv Cardiol; 2018 Dec; 31(6):717-724. PubMed ID: 30460719 [TBL] [Abstract][Full Text] [Related]